Potency Biomarkers for Mesenchymal Stem Cells
- 技術優勢
- This novel high-capacity assay developed to quantify the clonal heterogeneity in MSC potency is inexpensive and uses readily available antibodies. The potential market for this technology is large because it is applicable to MSC therapies for a variety of diseases and to the preparation of tissue samples with MSCs for drug development.
- 技術應用
- - Expedites the quantification and enrichment of multipotent progenitors in donor MSC preparations for research and clinical applications.- Enables the consistent and rapid production of highly efficacious MSC therapies from a variety of donors for a broad range of disorders- Useful screening tool in the clinical setting to monitor progenitor content in MSC therapies from different donors - Enables the rapid production of autologous MSC therapies with consistent efficacy among different patients- Improves the efficiency in production of MSC therapies for myocardial infarction and other acute, time-critical conditions
- 詳細技術說明
- None
- *Abstract
-
Novel biomarkers of MSC potency that will enable consistent and rapid production of highly efficacious MSC therapies from a variety of donors for numerous disorders.
- *Principal Investigation
-
Name: Kim O'Connor
Department:
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
